ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Cipla partners with MannKind for Afrezza – inhaled insulin
expressbpd
May 11, 2018Cipla has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for Afrezza in India. It is the only USFDA approved inhaled insulin available for patients suffering from diabetes.
Pharma Sources Insight January 2025
